(Q34058685)

30 July 2017

1 reference

title

Biotherapeutic targets for the treatment of allergic airway disease (English)

1 reference

30 July 2017

A J Coyle

1

1 reference

30 July 2017

C M Lloyd

series ordinal

2

1 reference

30 July 2017

J C Gutierrez-Ramos

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

30 July 2017

1 reference

30 July 2017

162

1 reference

30 July 2017

4 Pt 2

1 reference

30 July 2017

S179-84

1 reference

Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production

30 July 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Eosinophilia in transgenic mice expressing interleukin 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Interleukin-13: central mediator of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

T-cell co-stimulation through B7RP-1 and ICOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_3.15TAC8

10.1164/AJRCCM.162.SUPPLEMENT_3.15TAC8

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference